SARS-CoV-2 Surrogate Virus Neutralization Test

Description  The sVNT kit detects and measures circulating neutralizing antibodies against the SARS-CoV-2 virus. Neutralizing antibodies generated by the immune system after COVID-19 vaccination or infection function block the interaction between the receptor-binding domain (RBD) of the SARS-CoV-2 spike glycoprotein and the cell surface receptor human ACE2. Due to the crucial role of neutralizing antibodies, … Read more

CaniV-4 Test Kit

The Anigen Rapid CaniV-4 Test Kit is a chromatographic immunoassay for the qualitative detection of Heartworm antigen, Anaplasma phagocytophilum / Anaplasma platys antibodies, Borrelia burgdorferi antibodies and Ehrlichia canis antibodies in canine serum, plasma or whole blood. General information Dirofilaria immitis antigen determination, Ehrlichia canis antibody determination Determination of antibodies against Leishmania burgdorferi, Detection of … Read more

Direct PCR (Tail)

Description: DirectPCR Lysis Reagent Tail (patent pending) was specially developed for the lysis of mouse tail tissue. After brief heat treatment, crude lysates are used directly for PCR without time-consuming genomic DNA isolation. Specialized DirectPCR products are available for the lysis of mouse ears, yolk sacs, or cultured mammalian cells. Storage: Store DirectPCR-Tail protected from … Read more

TNF suppression and treatment effects of an anti-TNF monoclonal antibody

q-lead

Security and Tolerability of three CGRP Monoclonal Antibodies in Apply: A Retrospective Cohort Research Goal: We sought to evaluate the protection and tolerability of three calcitonin gene-related peptide (CGRP) monoclonal antibodies in sufferers with persistent migraine who have failed a number of courses of migraine preventive therapies. Background: CGRP is a crucial neuromodulator implicated within the pathogenesis of migraine. … Read more

preparation for the LC-MS/MS quantification of anti-cancer monoclonal antibodies

q-lead

Bottom-up sample preparation for the LC-MS/MS quantification of anti-cancer monoclonal antibodies in bio matrices Therapeutic monoclonal antibodies (mAbs) are rapidly taking over the treatment of many malignancies, and an astonishing number of mAbs is in development. This causes a high demand for quantification of mAbs in biomatrices both for measuring therapeutic mAb concentrations and to support pharmacokinetics … Read more

Neutralizing Monoclonal Antibodies Raised Against Lineage A Major Capsid Proteins

q-lead

Complete Evaluation of the Antigenic Impression of Human Papillomavirus Lineage Variation on Recognition by Neutralizing Monoclonal Antibodies Raised In opposition to Lineage A Main Capsid Proteins of Vaccine-Associated Genotypes Human papillomavirus (HPV) is the causative agent of cervical and different epithelial cancers. Naturally occurring variants of HPV have been categorised into lineages and sublineages primarily based upon … Read more

Tuning Monoclonal Antibody Galactosylation using Raman Spectroscopy-Controlled

q-lead

Tuning Monoclonal Antibody Galactosylation utilizing Raman Spectroscopy-Managed Lactic Acid Feeding A key side of large-scale manufacturing of biotherapeutics is a well-designed and consistently-executed upstream cell tradition course of. Course of Analytical Know-how (PAT) instruments present enhanced monitoring and management capabilities to help constant course of execution, and now have potential to help in upkeep of product high … Read more

Airway Delivery of Anti-influenza Monoclonal Antibodies Results in Enhanced Anti-Viral

q-lead

Receptor-binding domain-specific human neutralizing monoclonal antibodies in opposition to SARS-CoV and SARS-CoV-2 The outbreaks of extreme acute respiratory syndrome (SARS) and Coronavirus Illness 2019 (COVID-19) brought on by SARS-CoV and SARS-CoV-2, respectively, have posed extreme threats to world public well being and the financial system. Remedy and prevention of those viral illnesses name for the analysis and … Read more

characteristics of myeloproliferative neoplasms with concomitant monoclonal gammopathy

q-lead

Prevalence and traits of myeloproliferative neoplasms with concomitant monoclonal gammopathy Of BCR-ABL unfavourable myeloproliferative neoplasm (MPN) sufferers, 3-14 % show a concomitant monoclonal gammopathy (MGUS). Nonetheless, literature on co-occurring MPN and MGUS is scarce, the molecular underpinnings are unknown and it’s unclear whether or not sufferers require a particular administration. Right here, we in contrast the scientific … Read more